2016

1. Munoz-Quiles C, Lopez-Lacort M, Ubeda-Sansano I, Aleman-Sanchez S, Perez-Vilar S, Puig-Barbera J, et al. Population-based Analysis of Bronchiolitis Epidemiology in Valencia, Spain. Pediatr Infect Dis J. 2016;35(3):275-80.
 
2. Puig-Barbera J, Natividad-Sancho A, Trushakova S, Sominina A, Pisareva M, Ciblak MA, et al. Epidemiology of Hospital Admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: Results from the Global Influenza Hospital Surveillance Network. PLoS One. 2016;11(5):e0154970.
 
3. Qin Y, Zhang Y, Wu P, Feng S, Zheng J, Yang P, et al. Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15. Vaccine. 2016.
 

 

 

2015

1. Aristegui Fernandez J, Diez-Domingo J, Mares Bermudez J, Martinon Torres F. [Vaccination against hepatitis B. Impact of vaccination programmes after 20 years of use in Spain. Is it time for a change?]. Enferm Infecc Microbiol Clin. 2015;33(2):113-8.
 
2. Breva LP, Domingo JD, Martinez Beneito MA, Barbera JP. Vaccine coverage estimation using a computerized vaccination registry with potential underreporting and a seroprevalence study. Vaccine. 2015;33(18):2183-8.
 
3. Caballero-Perez P, Tuells J, Rementeria J, Nolasco A, Navarro-Lopez V, Aristegui J. [Acceptability of the HPV vaccine among Spanish university students in the pre-vaccine era: a cross-sectional study]. Rev Esp Quimioter. 2015;28(1):21-8.
 
4. Diez-Domingo J, Baldo JM, Planelles-Catarino MV, Garces-Sanchez M, Ubeda I, Jubert-Rosich A, et al. Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination. Influenza Other Respir Viruses. 2015;9(2):68-77.
 
 
6. Garces-Sanchez M, Renales-Toboso M, Boveda-Garcia M, Diez-Domingo J. [Measles, mumps, and rubella vaccine. Resurgence of measles in Europe]. Enferm Infecc Microbiol Clin. 2015;33(10):673-8.
 
7. Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087-96.
 
8. Navarro-Illana P, Caballero P, Tuells J, Puig-Barbera J, Diez-Domingo J. [Acceptability of human papillomavirus vaccine in mothers from Valencia (Spain)]. An Pediatr (Barc). 2015;83(5):318-27.
 
9. Perez-Vilar S, Diez-Domingo J, Lopez-Lacort M, Martinez-Ubeda S, Martinez-Beneito MA. Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain. BMC Infect Dis. 2015;15(1):811.
 
10. Perez-Vilar S, Diez-Domingo J, Puig-Barbera J, Gil-Prieto R, Romio S. Intussusception following rotavirus vaccination in the Valencia Region, Spain. Hum Vaccin Immunother. 2015;11(7):1848-52.
 
11. Puig-Barbera J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador F, Belenguer-Varea A, Carballido-Fernandez M, et al. Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results. Euro Surveill. 2015;20(8).
 
12. Puig-Barbera J, Tormos A, Trushakova S, Sominina A, Pisareva M, Ciblak MA, et al. The Global Influenza Hospital Surveillance Network (GIHSN): A new platform to describe the epidemiology of severe influenza. Influenza Other Respir Viruses. 2015.
 
13. Rondy M, Launay O, Puig-Barbera J, Gefenaite G, Castilla J, de Gaetano Donati K, et al. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Euro Surveill. 2015;20(2).
 
14. Vesikari T, Brodszki N, van Damme P, Diez-Domingo J, Icardi G, Petersen LK, et al. A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil(R) in 9-15-Year-Old Girls. Pediatr Infect Dis J. 2015;34(9):992-8.
 
15. Vesikari T, Østergaard L, Diez-Domingo J, Wysocki J, Flodmark C-E, Beeslaar J, et al. Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents. J Pediatric Infect Dis Soc. 2015.

 

 

2014

1. Martinon-Torres F, Gimenez-Sanchez F, Bernaola-Iturbe E, Diez-Domingo J, Jiang Q, Perez JL. A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants. Vaccine. 2014 Sep 8;32(40):5206-11

2. Navarro-Illana P, Aznar J, Diez-Domingo J. Ethical considerations of universal vaccination against human papilloma virus. BMC Med Ethics. 2014;15:29.

3. Navarro-Illana P, Diez-Domingo J, Navarro-Illana E, Tuells J, Aleman S, Puig-Barbera J. "Knowledge and attitudes of spanish adolescent girls towards human papillomavirus infection: where to intervene to improve vaccination coverage". BMC Public Health. 2014;14(1):490.

4. Pérez-Breva L, Villanueva RJ, Villanueva-Oller J, Acedo L, Santonja F, Moraño JA, et al. Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain). BMC Infect Dis. 2014;14(280).

5. Puig-Barbera J, Garcia-de-Lomas J, Diez-Domingo J, Arnedo-Pena A, Ruiz-Garcia M, Limon-Ramirez R, et al, Valencia Hospital Network for the Study of I, Respiratory Virus D. Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain. PLoS One. 2014;9(11):e112294.
 

6. Puig-Barbera J, Natividad-Sancho A, Calabuig-Perez J, Lluch-Rodrigo JA, Pastor-Villalba E, Martinez-Ubeda S, et al. Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: A comparative effectiveness study using the Valencia health care information system. Vaccine. 2014 Sep 22;32(42):5447-54.

7. Puig-Barbera J, Natividad-Sancho A, Launay O, Burtseva E, Ciblak MA, Tormos A, et al. 2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network. PLoS One. 2014;9(6):e100497.

8. Puig-Barbera J, Tormos A, Sominina A, Burtseva E, Launay O, Ciblak MA, et al. First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza season. BMC Public Health. 2014 Jun 5;14(1):564.

9. Rodriguez-Galan MA, Perez-Vilar S, Diez-Domingo J, Tuells J, Gomar-Fayos J, Morales-Olivas F, et al. [Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007-2011).]. Anales de Pediatria. 2014 Feb 26.

10.  Tuells J. [The public health in historical perspective.]. Gac Sanit. 2014;28:87-8. Spanish.

11.  van der Velden MV, Fritz R, Pöllabauer EM, Portsmouth D, Howard MK, Kreil TR, et al.uells J. Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population. J Infect Dis. 2014 Jan 1;209(1):12-23 

 

2013

1. Diez-Domingo J, Gurtman A, Bernaola E, Gimenez-Sanchez F, Martinon-Torres F, Pineda-Solas V, et al. Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain. Vaccine. 2013 Nov 4;31(46):5486-94

2. Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M,  et al. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine. 2013 Sep 13;31(40):4448-58

3. Lopez-Gigosos R, Campins M, Calvo MJ, Perez-Hoyos S, Diez-Domingo J, Salleras L, et al. Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler's diarrhea: A prospective cohort study. Hum Vaccin Immunother. 2013 Jan 16;9(3).

4. Morant-Talamante N, Diez-Domingo J, Martínez-Úbeda S, Puig-Barberá J, Alemán-Sánchez S, Pérez-Breva L. Herpes zoster surveillance using electronic databases in the Valencian Community (Spain). BMC Infect Dis. 2013 Oct 5;13(1):463.

5. Navarro López V, Hernández Belmonte A, Hernández Ros R, Tuells J. [Patient with human immunodeficiency virus infection and ulcerative    maculopapular skin lesions]. Med Clin (Barc). 2013 Oct 5;141(7):e13. Spanish

6. Pérez-Vilar S, Gutiérrez-Gimeno MV, Rodríguez-Galán MA, Díez-Domingo J, Puig-Barberà J, Gomar-Fayos J, et al. [Suspected adverse events to measles, mumps and rubella vaccine reported to the Community of Valencia Pharmacovigilance Centre]. An Pediatr (Barc). 2013 May;78(5):297-302

7.  Puig-Barberà J, Natividad-Sancho A, Calabuig-Pérez J, Lluch-Rodrigo JA, Pastor-Villalba E, Martínez-Úbeda S, et al. MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: Comparative effectiveness using the Valencia health care information system. Vaccine. 2013 Aug 20;31(37):3995-4002

8. Rodgers GL, Esposito S, Principi N, Gutierrez-Brito M, Diez-Domingo J, Pollard AJ, et al. Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule. Vaccine. 2013 Oct 1;31(42):4765-74

9. Rondy M, Puig-Barbera J, Launay O, Duval X, Castilla J, Guevara M, et al. 2011-12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study. PLoS One. 2013;8(4):e59681.

10. Tuells J. [On the use of the term "vaccinology" in Spanish]. Vacunas. 2013;14(1):1-3. Spanish.

11. Tuells J. [Reasons for an injury compensation programme for adverse vaccine-related events in Spain.]. Med Clin (Barc). 2013 Jun 18;140(12):554-7. Spanish.

12. Tuells J, Caballero P, Nolasco A. Creencias, actitudes e influencia de los medios de comunicación en trabajadores sanitarios españoles durante la gripe pandémica A (H1N1) 2009. Enferm Infecc Microbiol Clin. 2013;31(6):369-74.

13. Tuells J, Duro Torrijos JL. [The fruitless search for the cowpox to perpetuate the vaccine against smallpox]. Vacunas. 2013;14(1):53-57. Spanish.

14. Tuells J, Duro Torrijos JL. El papel del Marqués de Vadillo como propagador de la vacuna en Soria (1801). Vacunas. 2013;14(2):90-95

15. Tuells J, Duro Torrijos JL. [The second expedition of Balmis: revolution and vaccine.]. Gac Med Mex. 2013 May-June;149(3):377-384. Spanish    

16.  Tuells J, Duro Torrijos JL, Chilet Rosell E, Pastor Villalba E, Portero Alonso A, Navarro Ortiz C, et al. [News items on human papillomavirus and its vaccine in the Valencian press (2006-2011).]. Gac Sanit. 2013 Jul-Ago;24(4):374-7. Spanish.

2012

1. Diez-Domingo J, Patrzalek M, Cantarutti L, Arnould B, Meunier J, Soriano-Gabarro M, et al. The impact of childhood acute rotavirus gastroenteritis on the parents' quality of life: prospective observational study in European primary care medical practices. BMC Pediatr. 2012 May 31;12(1):58.
2. Esposito S, Cohen R, Domingo JD, Pecurariu OF, Greenberg D, Heininger U, et al. Antibiotic Therapy for Pediatric Community-Acquired Pneumonia: Do We Know When, What and For How Long to Treat? Pediatr Infect Dis J. 2012 Mar;31(6)e78-e85
3. Gossger N, Snape MD, Yu LM, Finn A, Bona G, Esposito S, et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA. 2012 Feb 8;307(6):573-82.
4. Martinon-Torres F, Gimenez-Sanchez F, Gurtman A, Bernaola E, Diez-Domingo J, Carmona A, et al. 13-valent Pneumococcal Conjugate Vaccine Given with Meningococcal C Tetanus Toxoid Conjugate and Other Routine Pediatric Vaccinations: Immunogenicity and Safety. Pediatr Infect Dis J. 2012 Apr;31(4):392-9
5. Soriano García E, Platero Sanchis L, Díez Domingo J. Adaptación del calendario de vacunación a los niños inmigrantes. Enferm. pediátr. 2012; 4(1): 2-5
6. Tuells J, Arístegui J. [Vaccinations in the Public Health Law: the 21 immunization schedules and so it goes]. Med Clin (Barc). 2012 Jun 2;139(1):13-5.
7. Tuells J. [The revision process of Francisco Xavier Balmis' translation of Moreau de la Sarthe's Historical and Practical Treatise on Vaccines.]. Gac Sanit. 2012 Jul-Aug;26(4):372-5.


2011
1. Acedo L, Moraño JA, Villanueva RJ, Villanueva-Oller J, Díez-Domingo J. Using random networks to study the dynamics of respiratory syncytial virus (RSV) in the Spanish region of Valencia. Mathematical and Computer Modelling. 2011;54(7-8):1650-54.
2. Díez-Domingo J, Baldo JM, Patrzalek M, Pazdiora P, Forster J, Cantarutti L, et al. Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis among children aged less than 5 years in six European countries. Eur J Pediatr. 2011 Feb;170(2):213-22.
3. Giménez-Sánchez F, Kieninger DM, Kueper K, Martinon-Torres F, Bernaola E, Díez-Domingo J, et al. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine. Vaccine. 2011 Aug 11;29(35):6042-6048.
4. Picazo JJ, de Arístegui Fernández J, Arteagoitia Axpe JM, Ordóñez DB, Gurrea AB, José XB, et al. Evidencias científicas disponibles sobre la seguridad de las vacunas. Vacunas.12(1):3-34.
5. Puig-Barberá J. 2010-2011 influenza seasonal vaccine, preliminary mid-season effectiveness estimates: reason for concern, confounding or are we following the right track? Euro Surveill. 2011 Mar 17;16(11).


2010
1. Acedo L, Díez-Domingo J, Morano JA, Villanueva RJ. Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications. Epidemiol Infect. 2010 Jun;138(6):853-60.
2. Acedo L, Moraño JA, Díez-Domingo J. Cost analysis of a vaccination strategy for respiratory syncytial virus (RSV) in a network model. Mathematical and Computer Modelling. 2010;52(7-8):1016-22.
3. Cebrián-Cuenca AM, Díez-Domingo J, Rodriguez MS, Puig-Barberá J, Navarro-Perez J. Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain). BMC Fam Pract. 2010;11:33.
4. Díez-Domingo J, Cantarino MV, Torrenti JM, Sansano MI, Rosich AJ, Merino AH, et al. A randomized, multicenter, open-label clinical trial to assess the immunogenicity of a meningococcal C vaccine booster dose administered to children aged 14 to 18 months. Pediatr Infect Dis J. 2010 Feb;29(2):148-52.
5. Díez-Domingo J, Flores SA, Martin JC, Klopfer SO, Schodel FP, Bhuyan PK. A randomized, multicenter, open-label clinical trial to assess the anamnestic immune response 4 to 8 years after a primary hepatitis B vaccination series. Pediatr Infect Dis J. 2010 Oct;29(10):972-4.
6. Díez-Domingo J, Garces-Sánchez M, Baldo JM, Planelles MV, Ubeda I, JuBert A, et al. Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase ii, randomized, open, controlled study. Pediatr Infect Dis J. 2010 Jun;29(6):e35-46.
7. Díez-Domingo J, Planelles-Cantarino MV, Baldo-Torrenti JM, Ubeda-Sansano I, Jubert-Rosich A, Puig-Barberá J, et al. Antibody persistence 12 months after a booster dose of meningococcal-C conjugated vaccine in the second year of life. Pediatr Infect Dis J. 2010 Aug;29(8):768-70.
8. Díez-Domingo J, Surinach NL, Alcalde NM, Betegon L, Largeron N, Trichard M. Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain. BMC Public Health. 2010;10:469.
9. Díez-Gandía A, Ajenjo MA, Navalon AB, Fernandez RB, Sanz AB, Díez-Domingo J. [Palatability of oral rehydration solutions (ORS) in healthy 6 to 9 year-old children. A multicentre, randomised single blind clinical trial]. An Pediatr (Barc). 2010 Feb;72(2):111-5.
10. Gutierrez-Gimeno MV, Martin-Moreno JM, Díez-Domingo J, Asensi-Botet F, Hernandez-Marco R, Correcher-Medina P, et al. Nosocomial rotavirus gastroenteritis in Spain: a multicenter prospective study. Pediatr Infect Dis J. 2010 Jan;29(1):23-7.
11. Marshall H, Nolan T, Díez Domingo J, Rombo L, Sokal EM, Mares J, et al. Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years. Vaccine. 2010 Jun 17;28(27):4411-5.
12. Puig-Barberá J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Perez-Vilar S, Silvestre-Silvestre E, et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain. A test-negative, hospital-based, case-control study. Vaccine. 2010 Nov 3;28(47):7460-7.
13. Tuells J MPE. Maurice Hilleman (1919-2005), el hombre que inventaba vacunas. Vacunas. 2010;11(1).
14. Tuells J MPE. Mujeres ante la gripe de 1918: la acreditación de las enfermeras. Vacunas. 2010;11(1).


2009
1. Arnedo-Pena A, Puig-Barberá J, Bellido-Blasco JB, Pac-Sa MR, Campos-Cruanes JB, Artero-Sivera A, et al. Risk factors and prevalence of asthma in schoolchildren in Castellon (Spain): a cross-sectional study. Allergol Immunopathol (Madr). 2009 May-Jun;37(3):135-42.
2. Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, De Juan Martin F, Díez Domingo J, Garces Sánchez M, et al. [Vaccination schedule of the Spanish association of pediatrics: recommendations 2009]. An Pediatr (Barc). 2009 Jan;70(1):72-82.
3. Gutierrez-Gimeno MV. Gastroenteritis aguda por rotavirus. Un problema en nuestros hospitales. Acta Pediatr Esp. 2009 67 (9):443-450
4. Ladhani S, Heath PT, Slack MP, McIntyre PB, Díez-Domingo J, Campos J, et al. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes. Clin Microbiol Infect. 2010 Jul;16(7):948-54.
5. Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montano LF, Nichol KL, et al. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine. 2009 Aug 13;27(37):5043-53.
6. Puig-Barberá J, Díez-Domingo J, Pastor-Villalba E, Garcia de Lomas J, Huertas-Zarco I, Perez-Hoyos S. Pertussis in adults with persistent cough: a prospective follow up study in primary care. Procedia in Vaccinology. 2009; 1 (1):73-80


2008
1. Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martin F, Díez Domingo J, Garces Sánchez M, et al. [Immunization schedule of the Spanish Association of Pediatrics: recommendations 2008]. An Pediatr (Barc). 2008 Jan;68(1):63-9.
2. Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martin F, Díez Domingo J, Garces Sánchez M, et al. [Criteria for including vaccines in the immunization schedule of the Spanish Association of Pediatrics]. An Pediatr (Barc). 2008 Jan;68(1):58-62.
3. Martinon-Torres F, Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martin F, Díez Domingo J, et al. [Why are pediatric empyemas on the increase in Spain?]. An Pediatr (Barc). 2008 Feb;68(2):158-64.
4. Pac-Sa MR, Museros-Recatala L, Arnedo-Pena A, Bellido-Blasco JB, Puig-Barberá J, Artero-Sivera A, et al. [Risk factors for symptoms of allergic rhinitis in adolescents in Castellon, Spain]. Rev Panam Salud Publica. 2008 May;23(5):333-40.


2006
1. Arnedo-Pena A, Puig-Barberá J, Aznar-Orenga MA, Ballester-Albiol M, Pardo-Serrano F, Bellido-Blasco JB, et al. Varicella vaccine effectiveness during an outbreak in a partially vaccinated population in Spain. Pediatr Infect Dis J. 2006 Sep;25(9):774-8.
2. Campins Marti M, Díez Domingo J. [Avian influenza: When the vaccine will be ready?]. Med Clin (Barc). 2006 Jun 17;127(3):93-5.
3. Díez Domingo J, Ridao Lopez M, Ubeda Sansano I, Ballester Sanz A. [Incidence and cost of hospitalizations for bronchiolitis and respiratory syncytial virus infections in the autonomous community of Valencia in Spain (2001 and 2002)]. An Pediatr (Barc). 2006 Oct;65(4):325-30.
4. Díez-Domingo J, Martin IO, Sanz AB, Lopez AG, Martinez CC, Boronat CP, et al. Rotavirus gastroenteritis among children under five years of age in Valencia, Spain. Pediatr Infect Dis J. 2006 May;25(5):455-7.
5. Lenne X, Díez Domingo J, Gil A, Ridao M, Lluch JA, Dervaux B. Economic evaluation of varicella vaccination in Spain: results from a dynamic model. Vaccine. 2006 Nov 17;24(47-48):6980-9.
6. Martinon-Torres F, Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, De Juan Martin F, Díez Domingo J, et al. [Human papillomavirus vaccines: a new challenge for pediatricians]. An Pediatr (Barc). 2006 Nov;65(5):461-9.
7. Pou-Bordoy J, Gene-Badia J, de la Camara-Gonzalez C, Berraondo-Zabalegui I, Puig-Barberá J. [Single management: an illusion without evidence]. Aten Primaria. 2006 Mar 15;37(4):231-4.
8. Puig-Barberá J, Márquez-Calderon S, Vila-Sánchez M. [Cardiac complications of major elective non-cardiac surgery: incidence and risk factors]. Rev Esp Cardiol. 2006 Apr;59(4):329-37.
9. Puig-Barberá J, Márquez-Calderon S. Complicaciones postoperatorias de origen cardiaco en mayores de 40 años: Validación de los índices de Detsky y de Lee: Derivación de un nuevo índice de predicción de riesgo. Valencia. Conselleria de Sanitat. 2006


2005
1. Arnedo Pena A, Puig Barberá J, Pardo Serrano F. [Varicella outbreak in a work center for psychologically handicapped adults]. Med Clin (Barc). 2005 Jun 18;125(3):95-7.
2. Díez-Domingo J, Delgado JD, Ballester A, Baldo JM, Planelles MV, Garces M, et al. Immunogenicity and reactogenicity of a combined adsorbed tetanus toxoid, low dose diphtheria toxoid, five component acellular pertussis and inactivated polio vaccine in six-year-old children. Pediatr Infect Dis J. 2005 Mar;24(3):219-24.
3. Díez-Domingo J, Gil A, San-Martin M, Gonzalez A, Esteban J, Baldo JM, et al. Seroprevalence of varicella among children and adolescents in Valencia, Spain. Reliability of the parent's reported history and the medical file for identification of potential candidates for vaccination. Hum Vaccin. 2005 Sep-Oct;1(5):204-6.
4. Garces-Sánchez MD, Díez-Domingo J, Ballester Sanz A, Peidro Boronat C, Garcia Lopez M, Anton Crespo V, et al. [Epidemiology of community-acquired pneumonia in children aged less than 5 years old in the Autonomous Community of Valencia (Spain)]. An Pediatr (Barc). 2005 Aug;63(2):125-30.
5. Puig-Barberá J. [Measurement of efficacy of influenza vaccination in elderly individuals. How and why]. Med Clin (Barc). 2005 Nov 19;125(18):695-6.
6. Roberton D, Marshall H, Nolan TM, Sokal E, Díez-Domingo J, Flodmark CE, et al. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children. Vaccine. 2005 Oct 17;23(43):5099-105